Abstract
Background The corpus callosum is the largest white matter pathway in the brain connecting the left and the right hemispheres. Developmental absence of the corpus callosum is a model disease for exploring disrupted connectivity and in turn understanding plasticity of the human brain, with atypically developing structure and function resulting in a highly heterogeneous clinical and cognitive profile. A proposed candidate for neuroplastic response in the context of this brain malformation is strengthening of intra-hemispheric pathways.
Methods To test this hypothesis, we assessed structural and functional connectivity at the whole-brain and regional level in a uniquely large cohort of children with agenesis of the corpus callosum (AgCC, n = 20) compared with typically developing controls (TDC, n = 29), and then examined associations with neurobehavioural outcomes using a multivariate data-driven approach.
Results For structural connectivity, children with AgCC showed a significant increase in intrahemispheric connectivity in addition to a significant decrease in inter-hemispheric connectivity compared with TDC. In contrast, for functional connectivity, children with AgCC and TDC showed a similar pattern of intra-hemispheric and inter-hemispheric connectivity. In AgCC, structural strengthening of the intra-hemispheric pathway was uniquely associated with verbal learning and memory, attention and executive measures.
Conclusions We observed structural strengthening of intra-hemispheric pathways in children born without corpus callosum, which seems to allow for functional connectivity comparable to a typically developing brain, and were relevant to explain neurobehavioural outcomes in this population. This neuroplasticity might be relevant to other disorders of axonal guidance, and developmental disorders in which corpus callosum alteration is observed.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the Boninchi Foundation from the University of Geneva, the Victorian Government s Operational Infrastructure Support Program and the Murdoch Children s Research Institute. Professor Amanda Wood is supported by a European Research Council Consolidator Fellowship [682734]. Associate Professor Richard Leventer is supported by a Melbourne Children s Clinician Scientist Fellowship. Professor Vicki Anderson was supported by the Australian National Health and Medical Research Council Senior Practitioner Fellowship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This project was approved by the Royal Children s Hospital (RCH) Human Ethics in Research Committee.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Ethical restrictions prevent us from making anonymized data available in a public repository. There are restrictions on data related to identifying participant information and appropriate ethical approval is required prior to release. Only de-identified data will be available (contact Vicki.Anderson{at}rch.org.au).
